Description     Claims     Drawing  

US4708871A   [0044] 
WO0243478A   [0047]  [0088]  [0195] 
WO02092812A   [0047]  [0088]  [0195] 
US6277962B   [0051] 
WO9512673A   [0051]  [0192]  [0268] 
US4036945A   [0074] 
US4331647A   [0074] 
US4946778A   [0075]  [0075] 
US5258498A   [0075] 
US6087329A   [0082] 
US5939598A   [0088]  [0089]  [0195]  [0195] 
WO9824893A   [0089]  [0195] 
WO9201047A   [0089]  [0195] 
WO9634096A   [0089]  [0195] 
WO9633735A   [0089]  [0195] 
US5413923A   [0089]  [0195] 
US5625126A   [0089]  [0195] 
US5633425A   [0089]  [0195] 
US5569825A   [0089]  [0195] 
US5661016A   [0089]  [0195] 
US5545806A   [0089]  [0195] 
US5814318A   [0089]  [0195] 
US5885793A   [0089]  [0195] 
US5916771A   [0089]  [0195] 
EP239400A   [0091] 
WO9109967A   [0091] 
US5225539A   [0091] 
US5530101A   [0091] 
US5585089A   [0091]  [0092] 
EP592106A   [0091] 
EP519596A   [0091] 
US5565332A   [0091] 
US5807715A   [0094] 
US4816567A   [0094] 
US4816397A   [0094] 
US4902614A   [0095] 
US4543439A   [0095] 
US4411993A   [0095] 
US5624820A   [0115] 
US5693508A   [0115] 
US5665577A   [0115] 
US6013516A   [0115] 
US5674703A   [0115] 
WO9205266A   [0115] 
WO9214829A   [0115] 
US5700470A   [0115] 
US5731172A   [0115] 
US5928944A   [0115] 
US5604090A   [0115] 
US5501979A   [0115] 
US5561063A   [0115] 
US5719054A   [0115] 
US4844904A   [0127] 
US5000959A   [0127] 
US4863740A   [0127] 
US4975282A   [0127] 
US5861397A   [0127] 
US5459127A   [0127] 
US4522811A   [0174] 
US6001358A   [0211]  [0215]  [0216] 
WO9521251A   [0268] 

J. Mol. Recognit.   [0044] 
IBC's 11th Antibody Engineering Meeting   [0047] 
Leukocyte Typing V: White Cell Differentiation Antigens   [0051] 
Curr. Opin. Biotechnol.   [0053] 
Analyst.   [0053] 
Biochem. Soc. Trans.   [0053] 
Nat. Med.   [0056] 
Immunity   [0056] 
J. Mol. Biol.   [0066] 
Proc. Natl. Acad. Sci. USA   [0066] 
Methods Mol Biol.   [0066] 
J. Mol. Biol.   [0066] 
Biochem Biophys Res Commun.   [0066] 
Methods Enymol.   [0074] 
Methods: A Companion to Methods in Enzymology   [0075] 
Science   [0075] 
Methods Enzymol.   [0075] 
Proc. Natl. Acad. Sci. USA   [0075] 
Science   [0075] 
Nat. Biotechnol.   [0089] 
Sequences of Proteins of Immunological Interest   [0090] 
Mol. Immunol.   [0090]  [0091] 
Mol. Immunol.   [0090]  [0091] 
Molecular Immunol.   [0091] 
Protein Engineering   [0091] 
Proc. Nat'l. Acad. Sci. USA   [0091] 
P.roc. Natl. Acad. Sci. USA   [0091] 
J. Immunol.   [0091] 
Nature   [0092] 
Science   [0094] 
BioTechniques   [0094] 
J. Immunol. Methods   [0094] 
Nature   [0094] 
Nature   [0094] 
Nature   [0094] 
Proc. Nat'l. Acad. Sci. USA   [0094] 
Nature   [0094] 
Nature   [0094] 
Nature   [0094] 
Hybridomas: A New Dimension in Biological Analyses   [0095] 
Antibodies: A Laboratory Manual   [0095] 
Cell   [0114] 
Proc: Natl. Acad. Sci. USA   [0115] 
Eukaryotic Viral Vectors   [0115] 
Mol. Cell. Biol.   [0115] 
Current Protocols in Molecular Biology   [0119] 
Methods in Enzymology   [0119] 
DNA Cloning   [0119] 
Methods in Enzymology   [0119] 
The Molecular Biology of the Yeast Saccharomyces   [0119] 
Remington: The Science and Practice of Pharmacy   [0175] 
Pharmaceutical Dosage Forms and Drug Delivery Systems   [0175] 
Handbook of Pharmaceutical Excipients American Pharmaceutical Association   [0175] 
Remington's Pharmaceutical Principles of Solid Dosage Forms   [0175] 
BBC's 11th Antibody Engineering Meeting   [0195] 
IBC's 13th Antibody Engineering Meeting   [0195] 
Int Rev Immunol   [0195] 
Nat Biotechnol   [0195] 
Nat Genet   [0195] 
Immunology   [0204] 
J Exp Med   [0205] 
Clin. Immunol.   [0205]  [0205] 
Nature   [0214]  [0265] 
Mol Immunol   [0214]  [0265] 
Sequences of proteins of immunological interest   [0214]  [0214] 
Mol Immunol   [0214] 
J Immunol   [0214] 
Blood   [0248] 
Proc Natl Acad Sci USA   [0248] 
J Biol Chem   [0248] 
Trends Immunol   [0248] 
Proc Natl Acad Sci U S A   [0248] 
Nat Immunol   [0248] 
Clin Immunol   [0255] 
Bone Marrow Transplant   [0257] 
Blood   [0257] 
Br J Haemato   [0257] 
Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis   [0268] 
Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells   [0268] 
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a ''humanized'' OKT3 monoclonal antibody   [0268] 
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody   [0268] 
CD2 sets quantitative thresholds in T cell activation   [0268] 
Signaling through OX40 (CD 134) breaks peripheral T-cell tolerance   [0268] 
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34   [0268] 
Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor   [0268] 
Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow-transplant recipients   [0268] 
CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles   [0268] 
CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis   [0268] 
Isotypes of IgG: comparison of the primary structures of three pairs of isotypes which differ in their ability to activate compliment   [0268] 
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions   [0268] 
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway   [0268] 
Attenuating lymphocyte activity: The crystal structure of the btla-hvem complex   [0268] 
Costimulation of T cells by OX40, 4-1BB, and CD27   [0268] 
The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA   [0268] 
Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4   [0268] 
Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation   [0268] 
A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator   [0268] 
The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion   [0268] 
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses   [0268] 
CD40 and CD154 in cell-mediated immunity   [0268] 
Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein   [0268] 
IgG subclass specificity or human monocyte receptor sites   [0268] 
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection   [0268] 
The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells   [0268] 
OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration   [0268] 
11th Antibody Engineering Meeting   [0268] 
Sequences of proteins of immunological interest   [0268] 
The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells   [0268] 
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth   [0268] 
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation   [0268] 
Cloned transchromosomic calves producing human immunoglobulin   [0268] 
Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle   [0268] 
Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells   [0268] 
The human OX40 homology cDNA structure, expression and chromosomal assignment of the ACT35 antigen   [0268] 
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation   [0268] 
Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo   [0268] 
The TNF and TNF receptor superfamilies: integrating mammalian biology   [0268] 
Human antibodies from transgenic mice   [0268] 
The expression and the regulatory role of OX40 and 4-iBB heterodimer in activated human T cells   [0268] 
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor   [0268] 
Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity   [0268] 
Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion   [0268] 
Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions   [0268] 
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts   [0268] 
CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen   [0268] 
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells   [0268] 
Regulation of CD4 T cell memory by OX40 (CD134)   [0268] 
Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation   [0268] 
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator   [0268] 
Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CDR40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3   [0268] 
The B7-CD28 superfamily   [0268] 
Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells   [0268] 
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40   [0268] 
Expression of gp34 (OX40 ligand) and OX40 on human T cell clones   [0268] 
Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice   [0268] 
In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions   [0268] 
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines   [0268] 
Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease   [0268] 
Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis   [0268] 
Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation   [0268] 
Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response   [0268] 
Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers   [0268] 
CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells   [0268] 
OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo   [0268] 
OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines   [0268] 
OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis   [0268] 
Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis   [0268] 
Cross-talk between activated human NK cells and CD4+T cells via OX40-OX40 ligand interactions   [0268]